Background:The purpose of this study was to evaluate the effectiveness of limited-resource hospitals in managing mild and moderate hospitalized cases of COVID-19 with comorbidities and in preventing their progression ...Background:The purpose of this study was to evaluate the effectiveness of limited-resource hospitals in managing mild and moderate hospitalized cases of COVID-19 with comorbidities and in preventing their progression to severe illness.Methods:Data were obtained from 88 moderate COVID-19 patients with comorbidities who were admitted to limitedresource hospitals.The data were classified into several parts:comorbidities,chronic medication before hospital admission,symptoms of COVID-19 before and during hospitalization,clinical features,laboratory findings on hospital admission,complications during hospitalization,as well as worst laboratory values during hospitalization,hospital stay,and outcomes.The clinical features,laboratory results,type of oxygen therapy used,and the final treatment outcome were all evaluated to assess for any potential relationship.Results:All patients were alive upon discharge.Before admission,the majority of patients(60.2%)received COVID-19 treatment,and the average hospital stay was 12 days.The most common symptoms were fever(88.7%),cough(95.5%),shortness of breath(90.9%),myalgia(84.1%),confusion(63.6%),headache(62.5%),sore throat(88.7%),rhinorrhea(17%),chest pain(58%),diarrhea(19.3%),nausea and vomiting(38.6%),anosmia(62.5%),as well as dysgeusia(64.8%).Based on chest radiograph or computed tomography(CT)scan,9.1%of the patients had unilateral pneumonia,90.9% had bilateral pneumonia,and 96.6% had multiple mottling and ground-glass opacity.Age was found associated with a significant increase in headache(p=0.005),rhinorrhea(p=0.013),chest pain(p=0.007),and the need for positive airway pressure(p=0.008).Between pre-and post-hospital admissions,there was a significant increase in lactate dehydrogenase and ferritin but a decrease in platelet,D-dimer,hemoglobin,lymphocytes,neutrophils,and total leucocyte count(p<0.001).There was a significant association between hospital stay and D-dimer level(p=0.05).Conclusion:Limited-resource hospitals in Egypt were efficient in managing mild and moderate hospitalized cases of COVID-19 with comorbidities.Many of these cases did not escalate to severe illness and were all alive upon discharge.Early management of COVID-19 tends to delay the disease progression to severe illness and improves patients5 chances of survival.Treating COVID-19 or using oxygen therapy at home can also delay the need for hospitalization in mild or moderate cases.展开更多
Whiteflies cause problems in vegetable production on a global scale. The primary worldwide whitefly pest is Bemisia tabaci (Gennadius). Insecticides are commonly used to mitigate the whitefly problem in vegetable crop...Whiteflies cause problems in vegetable production on a global scale. The primary worldwide whitefly pest is Bemisia tabaci (Gennadius). Insecticides are commonly used to mitigate the whitefly problem in vegetable crops. In limited-resource crop production, operator-carried spray applicators are commonly used for pesticide treatments. Three single-nozzle operator-carried spray applicators were assessed for their efficacies for whitefly (B. tabaci) control on summer squash (Cucurbita pepo L.) in Egypt. Each knapsack spray equipment was evaluated with five biorational and conventional insecticides. Counts of whitefly nymphs (first, second, third and fourth instars) on leaf samples were taken on 3, 9, 15 and 21 days after treatments with the insecticides. Nymphal mortality varied about 10% among the three spray equipment treatments. The Economy Micro Ulva sprayer resulted in significantly more nymphal mortality as compared with the Arimitsu sprayer and the CZP-3 sprayer, respectively. All insecticides greatly suppressed the whitefly populations;mean mortality ranged from 73% to 95% for all nymphs combined by day for a given treatment. These results provide pest management practitioners with performance assessment of the three operator-carried pesticide applicators for whitefly management with selected foliar insecticides.展开更多
High-risk neuroblastoma still has poor survival outcome. Improvement of outcome is attributed to the consolidation of chemotherapy by autologous bone marrow transplant. Further improvement of the outcome by tandem aut...High-risk neuroblastoma still has poor survival outcome. Improvement of outcome is attributed to the consolidation of chemotherapy by autologous bone marrow transplant. Further improvement of the outcome by tandem autologous transplant is followed by immune therapy. We aimed with this study to correlate initial disease characteristics with the outcome of transplanted high-risk neuroblastoma. A retrospective analysis was done for 73 transplanted patients. Patients were treated in Children’s Cancer Hospital Egypt from July 2012 to July 2015. Seventy patients received Busulphan/Melphalan conditioning. The 3-year overall survival (OS) and event-free survival (EFS) was 63.3% and 51.3%, respectively. Disease stage did not impact the OS and EFS, P = 0.54 and 0.62 respectively. Status of MYCN did not reflect statistically on outcome for tumors with amplified compared to nonamplified (EFS, 49% and 63.1%, respectively). Response after induction chemotherapy pointed that patients who had objective response (complete response, very good partial response and partial response) were better compared to those with less response with EFS and OS of 53.3% and 64.2% compared to 49.3% and 63.5%, respectively, which may indicate that chemo-sensitive tumors have better outcome. By the end of the study, twenty-seven patients relapsed, out of them 25 patients died. Pretransplant risk features for neuroblastoma was nullified by autologous stem cell transplant. The modest outcome observed, highlights some limitations that need to be sorted out in countries with limited resources. The introduction of immune therapy and tandem transplant is needed to achieve a better outcome, yet it adds to more financial burden.展开更多
文摘Background:The purpose of this study was to evaluate the effectiveness of limited-resource hospitals in managing mild and moderate hospitalized cases of COVID-19 with comorbidities and in preventing their progression to severe illness.Methods:Data were obtained from 88 moderate COVID-19 patients with comorbidities who were admitted to limitedresource hospitals.The data were classified into several parts:comorbidities,chronic medication before hospital admission,symptoms of COVID-19 before and during hospitalization,clinical features,laboratory findings on hospital admission,complications during hospitalization,as well as worst laboratory values during hospitalization,hospital stay,and outcomes.The clinical features,laboratory results,type of oxygen therapy used,and the final treatment outcome were all evaluated to assess for any potential relationship.Results:All patients were alive upon discharge.Before admission,the majority of patients(60.2%)received COVID-19 treatment,and the average hospital stay was 12 days.The most common symptoms were fever(88.7%),cough(95.5%),shortness of breath(90.9%),myalgia(84.1%),confusion(63.6%),headache(62.5%),sore throat(88.7%),rhinorrhea(17%),chest pain(58%),diarrhea(19.3%),nausea and vomiting(38.6%),anosmia(62.5%),as well as dysgeusia(64.8%).Based on chest radiograph or computed tomography(CT)scan,9.1%of the patients had unilateral pneumonia,90.9% had bilateral pneumonia,and 96.6% had multiple mottling and ground-glass opacity.Age was found associated with a significant increase in headache(p=0.005),rhinorrhea(p=0.013),chest pain(p=0.007),and the need for positive airway pressure(p=0.008).Between pre-and post-hospital admissions,there was a significant increase in lactate dehydrogenase and ferritin but a decrease in platelet,D-dimer,hemoglobin,lymphocytes,neutrophils,and total leucocyte count(p<0.001).There was a significant association between hospital stay and D-dimer level(p=0.05).Conclusion:Limited-resource hospitals in Egypt were efficient in managing mild and moderate hospitalized cases of COVID-19 with comorbidities.Many of these cases did not escalate to severe illness and were all alive upon discharge.Early management of COVID-19 tends to delay the disease progression to severe illness and improves patients5 chances of survival.Treating COVID-19 or using oxygen therapy at home can also delay the need for hospitalization in mild or moderate cases.
文摘Whiteflies cause problems in vegetable production on a global scale. The primary worldwide whitefly pest is Bemisia tabaci (Gennadius). Insecticides are commonly used to mitigate the whitefly problem in vegetable crops. In limited-resource crop production, operator-carried spray applicators are commonly used for pesticide treatments. Three single-nozzle operator-carried spray applicators were assessed for their efficacies for whitefly (B. tabaci) control on summer squash (Cucurbita pepo L.) in Egypt. Each knapsack spray equipment was evaluated with five biorational and conventional insecticides. Counts of whitefly nymphs (first, second, third and fourth instars) on leaf samples were taken on 3, 9, 15 and 21 days after treatments with the insecticides. Nymphal mortality varied about 10% among the three spray equipment treatments. The Economy Micro Ulva sprayer resulted in significantly more nymphal mortality as compared with the Arimitsu sprayer and the CZP-3 sprayer, respectively. All insecticides greatly suppressed the whitefly populations;mean mortality ranged from 73% to 95% for all nymphs combined by day for a given treatment. These results provide pest management practitioners with performance assessment of the three operator-carried pesticide applicators for whitefly management with selected foliar insecticides.
文摘High-risk neuroblastoma still has poor survival outcome. Improvement of outcome is attributed to the consolidation of chemotherapy by autologous bone marrow transplant. Further improvement of the outcome by tandem autologous transplant is followed by immune therapy. We aimed with this study to correlate initial disease characteristics with the outcome of transplanted high-risk neuroblastoma. A retrospective analysis was done for 73 transplanted patients. Patients were treated in Children’s Cancer Hospital Egypt from July 2012 to July 2015. Seventy patients received Busulphan/Melphalan conditioning. The 3-year overall survival (OS) and event-free survival (EFS) was 63.3% and 51.3%, respectively. Disease stage did not impact the OS and EFS, P = 0.54 and 0.62 respectively. Status of MYCN did not reflect statistically on outcome for tumors with amplified compared to nonamplified (EFS, 49% and 63.1%, respectively). Response after induction chemotherapy pointed that patients who had objective response (complete response, very good partial response and partial response) were better compared to those with less response with EFS and OS of 53.3% and 64.2% compared to 49.3% and 63.5%, respectively, which may indicate that chemo-sensitive tumors have better outcome. By the end of the study, twenty-seven patients relapsed, out of them 25 patients died. Pretransplant risk features for neuroblastoma was nullified by autologous stem cell transplant. The modest outcome observed, highlights some limitations that need to be sorted out in countries with limited resources. The introduction of immune therapy and tandem transplant is needed to achieve a better outcome, yet it adds to more financial burden.
